Aptevo Therapeutics (NASDAQ:APVO) just reported results for the first quarter of 2024.
- Aptevo Therapeutics reported earnings per share of -$9.95. This was above the analyst estimate for EPS of -$12.84.
- The company did not report any revenue for the quarter.